Summary Between 1972 and 1982, 60 patients with histologically proven duct carcinoma in situ (DCIS) without evidence of invasive disease were treated by surgery alone. Treatment was not randomised and was total mastectomy (19), subcutaneous mastectomy (6) or local excision (35). Follow-up was by clinical examination and mammography with a median follow-up of 9 years (range 4-16 years). Twenty-six patients (43%) have recurred locally. The estimated proportion recurrence free at 7 years is 59% (95% CI 46-72%). Local recurrence on the chest wall occurred in one patient having total mastectomy and in the chest wall or nipple in three patients having subcutaneous mastectomy. Twenty-two patients recurred locally in the breast after conservative surgery. The 7-year recurrence-free rates were 94%, 44% and 45% respectively in the three groups. Of those patients who recurred locally 14/26 (54%) did so with invasive disease. Of the 34 who did not develop local recurrence, two developed metastases. The only factor which correlated with local recurrence and invasive local recurrence on multivariate analysis was conservative surgery (hazard ratio 4.71 (1.59-14.0),
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Duct carcinoma in situ (DCIS) is traditionally treated by mastectomy. Theoretical arguments in favour of this approach include eradication of multicentric foci of DCIS, eradication of occult invasive foci in other breast quadrants and prevention of local recurrence from residual DCIS. Success following mastectomy for DCIS is demonstrated by local recurrence rates at 5 years of between 0 and 9.2% (Ashikari et al., 1971 (Ashikari et al., , 1977 Sunshine et al., 1985; Farrow, 1970; Westbrook & Gallager, 1975) and survival rates of 95% at 10 years (Sunshine et al., 1985) .
However, as conservation of the breast is becoming increasingly important in the management of early stage invasive breast cancer and with the anticipated rise in diagnosis of patients with DCIS following the introduction of a national screening programme, a more conservative approach to treatment of pure DCIS may be appropriate.
A retrospective analysis has been undertaken to define predictors of local recurrence and progression in patients treated by surgery alone for pure duct carcinoma in situ in an attempt to draw conclusions about optimal therapy. Representative H & E sections were reviewed by one of us (B.G). Margins of excision were assessed from the surgical and pathological reports at the time of operation and were judged to be complete in 53 (88%) cases.
Materials and methods

All
Follow-up was available in all patients; (median 9 years, range 4-16 years). Follow-up included three monthly clinical examinations for the first two years and then at increasing intervals. Patients who had been treated by local excision also had yearly mammography. Aspiration cytology was not performed routinely unless suspicious areas were found clinically or radiographically.
Multivariate analysis was performed using Cox's regression in a stepwise fashion.
Results
Patient clinical characteristics are shown in Table I Figure 1 demonstrates the actuarial time to local recurrence in the breast. Local recurrence occurred at regular intervals throughout follow-up in each of the three treatment groups. Local recurrence with invasive disease similarly occurred steadily over time (Figure 2 ).
There were only seven deaths, three of which were attributed to causes other than cancer. Overall survival showed a trend favouring patients with local excision (X2 trend = 3.45, P<0.06). Seven-year survival rates were 97%, 100% and 78% for the local excision, subcutaneous mastectomy and total mastectomy groups respectively.
There was no evidence of an improved recurrence free rate in 12 patients who were asymptomatic compared with those who were symptomatic at presentation (X2 = 0.63, n.s.). There was no difference in recurrence free rates between patients presenting with a lump and nodularity and those presenting without (X2 = 0.05, n.s.).
Treatment of the local recurrence depended on the original treatment of the primary tumour and whether invasive disease had developed (Table III) , Local (n = 35); -----, subcutaneous mastectomy (n = 6); -, total mastectomy (n = 19).
was usually treated conservatively again. Four of the eight of those treated by local excision for their first local recurrence have recurred a second time within the breast, all at or near the original site of disease. Two of these four have progressed to invasive disease at second recurrence.
Univariate and multivariate analysis were performed to determine predictors of local recurrence and invasive local recurrence. The only factor which correlated with both local and invasive recurrence on multivariate analysis was conservative surgery. The results are summarised in Table IV Discussion DCIS has traditionally been treated by mastectomy with the aim of cure. There are three main arguments in favour of this approach. First, the eradictation of multicentre foci of DCIS suspected to be present in the rest of the breast. Multicentric foci have been reported in 13-40% of breasts at subgross sectioning (Fisher et al., 1975; Lagios, 1977; Lagios et al., 1982; Schwartz, 1980) . Second, the removal of occult invasive disease at foci in other breast quadrants. This is estimated as occurring in 6-21% of breasts after excision of DCIS (Brown et al., 1976; Lagios et al., 1982; Rosen et al., 1979) . Finally, mastectomy should prevent local recurrence or invasive disease arising from residual DCIS after local excision. The high incidence of this residue can be as high as 56% in mastectomy specimens following initial excision of DCIS (Rosen et al., 1979) .
Recently, a more conservative approach to treatment of pure DCIS has been advocated with the emergence of conservative management of early stage breast cancer and a reluctance to treat preinvasive disease more radically than invasive disease. With the introduction of national screening programmes the diagnosis of pure DCIS is expected to rise and with it the expectation of breast conserving surgery.
Local recurrence following local excision alone in this group of patients is 55% at 7 years. This compares with a local recurrence rate of 23% at 3 years and 15% at 4 years reported in two other series following excision alone for DCIS (Fisher et al., 1986; Lagios et al., 1982) . Two cases recurred within 6 months of local excision and were thought to represent incompletely excised tumour. Recurrences have continued to appear throughout the follow-up period. While local recurrence within the breast is generally controllable, the concern is that cure has been jeopardised, as recurrence carries with it the risk of progression to invasive disease.
Local recurrence in this series carries a 54% risk of progression to invasive disease, which is similar to that reported in four series in which DCIS had been treated with breast conservation (Fisher et al., 1986; Montague, 1984; Recht et al., 1985; Zafrani et al., 1986) .
From our series it would appear difficult to predict clinically or pathologically those individual patients who are likely to recur or progress. Pathological categories defining precise extent of disease were not used as these could only be correctly designated if all the tumour was examined with multiple sections; this must be combined with an accurate assessment of the extent of the disease using subgross analysis in conjunction with adequate margin sampling. Tumour size did not predict for progression to invasive disease; but less than half of our cases presented with a palpable tumour. There was no difference in recurrence free rates between the group with or without tumour. This is contrary to suggestions by Lagios et al., (1982) that the degree of multicentricity and occult invasion are related to tumour size.
In future selection of patients who are most likely to recur or progress may depend on other biological markers. For example, it has been suggested that tumour ploidy (Carpenter et al., 1987) may be associated with an increased likelihood of recurrence. The over expression of the oncogene c-erbB-2 reported in 44% of evaluable DCIS cases presenting to this breast unit (Gusterson et al., 1988) may provide a marker of biologically distinct local disease and is to be investigated further.
From our experience it would appear that local excision alone may be inadequate local treatment for patients presenting with DCIS. Furthermore, judging from the six patients in the group, subcutaneous mastectomy would appear to offer no advantage over a more conservative approach. In one of these patients diagnosis of local recurrence may have been delayed due to the tense capsule around the prosthesis. Mastectomy offers the best hope of local control for DCIS raising at least the probability of cure, but this still carries a small risk of local recurrence and metastatic disease. The former could come from residual foci after 'incomplete' mastectomy and the latter from undetected (micro) invasive foci.
Follow-up and survival data are not sufficient at present to enable a comparative statement to be made. Conclusions about optimal therapy which may be drawn from these pateints may not be applicable in the future when an increasing number of patients are diagnosed by screening mammography at either an earlier stage of disease or even with an entirely different biological disease.
Local excision followed by breast irradiation may provide an alternative approach for some patients, and results of the EORTC Protocol (10853) and NSABP (B17) prospective trials comparing local excision with local excision and radiotherapy for DCIS both presenting with symptoms and at screening are awaited.
In conclusion, until biological markers are found for those tumours most likely to recur or progress to invasive disease, conservative surgery for DCIS should only be considered if careful follow-up is available and the risks of local recurrence accepted. This work underlines the need for a national policy for disease management and clinical trials in screen-detected DCIS.
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